FDA approves Keytruda for certain patients with locally advanced or metastatic urothelial carcinoma May 19, 2017 No Comments
European Commission approves dinutuximab beta for the treatment of high-risk neuroblastoma May 11, 2017 No Comments
FDA approves Tymlos for postmenopausal women with osteoporosis at high risk for fracture May 3, 2017 No Comments
FDA grants accelerated approval to Imfinzi for previously treated bladder cancer May 2, 2017 No Comments
FDA approves Stivarga for second-line treatment of hepatocellular carcinoma April 28, 2017 No Comments
RSS